Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

9.0%

6 terminated out of 67 trials

Success Rate

82.4%

-4.2% vs benchmark

Late-Stage Pipeline

9%

6 trials in Phase 3/4

Results Transparency

36%

10 of 28 completed with results

Key Signals

10 with results82% success

Data Visualizations

Phase Distribution

41Total
Not Applicable (17)
P 1 (13)
P 2 (5)
P 3 (2)
P 4 (4)

Trial Status

Completed28
Recruiting16
Not Yet Recruiting7
Terminated6
Active Not Recruiting4
Unknown4

Trial Success Rate

82.4%

Benchmark: 86.5%

Based on 28 completed trials

Clinical Trials (67)

Showing 20 of 20 trials
NCT04777539CompletedPrimary

Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis

NCT04926818Phase 3Active Not RecruitingPrimary

Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis

NCT06157086Active Not RecruitingPrimary

Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in France

NCT06860932Not ApplicableRecruitingPrimary

A Palliative Care Model Impact on Knowledge and Attitudes

NCT07523100Phase 1Not Yet RecruitingPrimary

A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis.

NCT07526493Phase 1RecruitingPrimary

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

NCT06053749Active Not RecruitingPrimary

An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden

NCT07195110CompletedPrimary

Prevalence of Periodontitis in Egyptian Multiple Sclerosis Patients.

NCT07474129Not ApplicableNot Yet RecruitingPrimary

Serious Game Rehabilitation and Brain Plasticity in MS

NCT05359653Phase 1RecruitingPrimary

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

NCT04819737Not ApplicableRecruitingPrimary

Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences

NCT06800144Not ApplicableRecruitingPrimary

Effect of Music Therapy on Pain in People With Multiple Sclerosis

NCT07444047Not Yet RecruitingPrimary

MRI-Based Lesion Differentiation in Older Patients With Multiple Sclerosis

NCT07341828Phase 1Not Yet RecruitingPrimary

A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy

NCT06583967Not ApplicableCompletedPrimary

The Effect of Aerobic Exercise on an Elliptical Trainer Versus a Treadmill, in People With Multiple Sclerosis

NCT07313462RecruitingPrimary

Escalation vs. Induction Therapy Strategy in Patients With Early-Onset MS After Age 50

NCT05633875RecruitingPrimary

Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis

NCT04121468Phase 1RecruitingPrimary

A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis

NCT06957145RecruitingPrimary

Vista Protein Expression of Monocyte and T Cell Subsets in Multiple Sclerosis and Its Clinical Correlation

NCT05000216Phase 2Terminated

COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

Scroll to load more

Research Network

Activity Timeline